What Will RFK Jr. Do to US Healthcare? A Comprehensive Analysis of HHS Secretary Kennedy’s First 15 Months
As Health and Human Services Secretary Robert F. Kennedy Jr. completes his first 15 months in office, the nation is witnessing one of the most dramatic transformations of federal health policy in modern history. From vaccine advisory committees to Medicaid funding, from supplement regulation to rural health initiatives, Kennedy’s tenure has been marked by bold moves, fierce controversy, and a fundamental restructuring of how the federal government approaches public health.
This comprehensive analysis examines what RFK Jr. has already done, what he plans to do next, and what these changes mean for employers, patients, and the American healthcare system.
The Philosophy: “Make America Healthy Again”
Kennedy’s guiding vision is encapsulated in the “Make America Healthy Again” (MAHA) initiative, a framework that prioritizes chronic disease prevention, food quality, and what he calls “ending the era of federal policies that fueled the chronic disease epidemic.”
“We stand at a generational turning point,” Kennedy told the House Ways & Means Committee in April 2026. “Our children are the sickest generation in modern history, and decades of failed policy captured agencies and profit-driven systems have caused it.”
This philosophy has translated into action across virtually every HHS agency, from the CDC and FDA to CMS and the National Institutes of Health.
Major Policy Changes Already Implemented
1. Vaccine Policy Overhaul
Perhaps the most contentious area of Kennedy’s tenure has been his approach to vaccines. While Kennedy has stated that the MMR vaccine is “safe and effective” for most people and that his department has “advised every child” to get it, his actions tell a more complex story.
Key changes include:
- Reconstitution of ACIP: Kennedy removed every sitting member of the CDC’s Advisory Committee on Immunization Practices (ACIP), replacing them with appointees whose vaccine expertise has been questioned. A federal judge has since blocked this reconstituted committee, ruling that the appointments likely violated the Federal Advisory Committee Act.
- Childhood vaccine schedule changes: The administration changed the childhood vaccine schedule to no longer recommend the MMRV vaccine for children under 4 years old.
- ACIP recommendation reversals: The new committee voted to end the universal recommendation for the Hepatitis B vaccine for newborns.
Legal setback: In March 2026, a federal district court judge issued a preliminary injunction blocking the administration from implementing changes to the childhood vaccine schedule championed by Kennedy. Judge Brian Murphy ruled that Kennedy’s reconstitution of ACIP likely violated federal law, finding “significant gaps in vaccine expertise among the panel’s newly appointed members.”
2. Preventive Services Task Force Erosion
The U.S. Preventive Services Task Force (USPSTF)—a panel of medical experts responsible for recommending preventive services like cancer screenings—has not met since March 2025. Kennedy canceled all remaining meetings for the year, and after nearly one-third of its members’ terms ended in December 2025, he announced no plans to replace them.
The task force also failed to submit its legally required annual report to Congress identifying critical research gaps to determine funding priorities. Public health experts warn that this erosion could seriously endanger preventive care access for millions of Americans.
3. Vaccine Court and Conflict of Interest Concerns
In July 2025, Kennedy announced he was working with the Department of Justice to “fix” the Vaccine Injury Compensation Program (VICP). Critics, including four Democratic senators, have raised significant conflict of interest concerns given Kennedy’s close ties to the anti-vaccine litigation industry.
The conflict concerns include:
- Kennedy, his family, and the law firm Wisner Baum—where he previously worked—have made millions referring and representing claimants before VICP.
- Kennedy turned over his stake in one major case to his son after pressure from Senator Elizabeth Warren.
- Kennedy appointed longtime ally and vaccine court litigator Drew Downing to make changes to VICP. Downing had at least 60 cases pending in VICP prior to his appointment.
- Kennedy’s close ally and campaign advisor Aaron Siri, whose firm had more than 100 cases pending before VICP in 2025, could potentially benefit from proposed changes.
The senators wrote in a January 2026 letter: “The direct financial stake your family and Wisner Baum may have in pending vaccine litigation casts a cloud over any changes you may make to VICP.”
4. Medicaid and Budget Restructuring
Kennedy has defended the administration’s approach to Medicaid against charges of deep cuts. His argument? Overall spending on the program is projected to rise over the next decade.
However, critics say this masks nearly $1 trillion in reductions:
- The Congressional Budget Office estimates federal Medicaid spending will be reduced by close to $1 trillion over the next decade compared with prior projections.
- The Kaiser Family Foundation concludes the bulk of projected savings comes from work requirements and restrictions on how states raise their share of Medicaid funding.
- A RAND Corporation analysis found state Medicaid budgets are projected to decline by hundreds of billions of dollars over the next decade, with some states facing reductions of 5% or more.
“Only in Washington is it considered a cut,” Kennedy told Senator Ben Ray Luján during a hearing. But health policy experts counter that measuring against a baseline—what the program would have cost if existing law remained unchanged—reveals real reductions.
“The federal government is spending nearly a trillion dollars less than it otherwise would have in the absence of the legislation,” said Edwin Park, a research professor at Georgetown University’s Center for Children and Families.
5. ACA Exchange Regulations
The administration has implemented new regulations for the Affordable Care Act exchange system that critics argue will harm the individual health insurance market. Key changes include:
- An 86% reduction in spending on exchange marketing and navigator services, to $72 million.
- New anti-fraud regulations that the administration predicts will cause the number of exchange users to fall sharply.
Main Street Alliance and several cities sued Kennedy over ACA exchange changes, arguing they violate the Administrative Procedures Act and would “significantly harm” small businesses that send their employees to the ACA exchange for coverage.
6. Supplement Industry Support
Kennedy has positioned himself as a champion of the supplement industry, which is a $70 billion, lightly regulated U.S. market. He has vowed to “end the war on vitamins” and surrounded himself with wellness influencers who have ties to supplement businesses.
This represents a significant shift from previous administrations’ focus on FDA oversight of supplements, which are not subject to the same pre-market approval requirements as pharmaceutical drugs.
7. Drug Pricing Initiatives
On the pharmaceutical front, Kennedy has announced:
- Most-favored-nation pricing agreements with 16 major pharmaceutical companies, a policy intended to ensure Americans pay no more for medications than patients in other wealthy nations.
- Hospital price transparency enforcement efforts.
- Prior-authorization reform discussions with health insurance executives.
8. Food and Nutrition Policy
Kennedy has emphasized food quality as a public health priority:
- HHS and the USDA have issued new dietary guidelines emphasizing whole foods.
- More than 50 medical schools have committed to expanding nutrition education from an average of two hours to 40 hours.
- More than 40% of the food industry has committed to phasing out petroleum-based artificial dyes.
- The FDA has approved six natural food colorings derived from fruits and vegetables.
9. Rural Health Initiatives
The administration has launched the $50 billion Rural Health Transformation Fund—described as the largest federal investment in rural health in the nation’s history. HHS has also committed more than $135 million to expand rural medical residency programs and nutrition services.
What’s Next: Priorities for the Remainder of 2026 and Beyond
Site-Neutral Payment Reforms
Kennedy has identified site-neutral payments as a key priority. Currently, Medicare pays significantly more for the same outpatient service when performed in a hospital setting versus an independent physician’s office. This disparity has accelerated the consolidation of independent practices into hospital systems—from 80% independent 15 years ago to just 20% today.
“Site neutrality, which we’re fixing, is key to that,” Kennedy told the House Ways & Means Committee, referring to restoring independent practice viability.
Association Health Plans
Senator Rand Paul has been lobbying Kennedy to support association health plans (AHPs), which would allow small employers to team up across state lines to purchase health coverage. While Kennedy has not committed to AHPs directly—steering conversation toward HSAs instead—the administration’s position on this issue remains in development.
Continued HHS Budget Cuts
The administration’s Fiscal Year 2027 budget proposal cuts $17 billion (14%) from programs under the LHHS subcommittee jurisdiction. These cuts include:
- A nearly $6 billion (12%) cut to the National Institutes of Health
- A $3 billion (more than 30%) cut to the Centers for Disease Control
- A $2.2 billion cut to Health Resources Services Administration
- Complete elimination of Title X family planning programs
- Complete elimination of the Low Income Home Energy Assistance Program (LIHEAP)
Under Kennedy’s leadership, the NIH has already awarded 22% (2,235) fewer new research grants than in the prior year.
Vaccine Policy Evolution
Despite legal setbacks, the administration continues to pursue vaccine policy changes. The future of ACIP appointments, the childhood vaccine schedule, and the Vaccine Injury Compensation Program remain active areas of policy development.
Public Opinion and Political Landscape
Kennedy’s popularity is polarized. Overall, six in ten voters disapprove of the way Kennedy is handling his job as HHS Secretary. However, his approval ratings are strong within specific groups:
- Among MAGA supporters: 88% approve.
- Among MAHA supporters (43% of all voters): about seven in ten approve.
However, even among MAHA supporters, only a third “strongly” approve of his performance, and nearly one-third disapprove—tepid ratings for a group that aligns with his signature movement.
Trust in federal health agencies has declined during Kennedy’s tenure, with concerns about agency independence and decision-making capabilities crossing partisan lines.
Implications for Employers
For employers navigating this changing landscape, several key considerations emerge:
1. Medicaid Changes Could Affect Workforce
If Medicaid work requirements lead to coverage losses for low-income workers, employers may see increased pressure to offer affordable coverage or face workforce instability.
2. ACA Exchange Instability
Lawsuits challenging ACA exchange regulations could create uncertainty for small employers who direct employees to the exchanges for coverage. The Main Street Alliance lawsuit highlights concerns that these changes could make exchange coverage unaffordable or inadequate.
3. Association Health Plans
If the administration moves forward with association health plans, small employers may gain new options for purchasing coverage across state lines. However, critics warn this could destabilize the fully insured small-group market.
4. Preventive Care Access
The erosion of the U.S. Preventive Services Task Force could affect which preventive services are recommended and covered without cost-sharing—a key consideration for employer plan design.
5. Drug Pricing Trends
Most-favored-nation drug pricing agreements could affect employer prescription drug costs, though the full impact remains to be seen.
6. Site-Neutral Payments and Provider Networks
If site-neutral payment reforms succeed, they could slow hospital consolidation and potentially affect provider networks and reimbursement rates.
Conclusion
Robert F. Kennedy Jr.’s tenure as HHS Secretary represents a fundamental shift in federal health policy direction. His “Make America Healthy Again” agenda has already produced significant changes across vaccine policy, preventive services, Medicaid, the ACA exchanges, drug pricing, and food regulation.
Whether these changes will achieve Kennedy’s stated goal of reversing the chronic disease epidemic and lowering costs—or will instead undermine public health infrastructure and increase coverage losses—remains an open question. What is clear is that employers, patients, and healthcare providers must prepare for continued volatility as the administration’s policies face legal challenges, congressional oversight, and the ultimate test of real-world outcomes.
As Kennedy told the House Ways & Means Committee: “We can reverse the chronic disease epidemic, improve public health and lower costs. I stand ready to work with this committee and Congress to seize this opportunity.”
Whether America is ready to seize that opportunity—and at what cost—will define the legacy of RFK Jr.’s tenure at HHS.
Key Takeaways
- RFK Jr. has reconstituted ACIP, changed childhood vaccine schedules, and faces legal challenges.
- The USPSTF has not met since March 2025, endangering preventive care access.
- Medicaid faces nearly $1 trillion in projected reductions over the next decade.
- ACA exchange marketing has been cut by 86%, facing legal challenges.
- Most-favored-nation drug pricing agreements have been signed with 16 pharmaceutical companies.
- The $50 billion Rural Health Transformation Fund is the largest rural health investment in US history.
- Employers should monitor Medicaid, ACA exchanges, AHPs, preventive care coverage, and drug pricing trends.
This analysis was published on May 15, 2026, and reflects policy developments through the first 15 months of Secretary Kennedy’s tenure.
